First, I just want to like summarize, like sum this up is that these gbl ones have shown meaningful protection for your heart and your brain
In the OASIS 1 trial, patients took a 50 mg daily dose meaning a monthly supply contains roughly 1,500 mg of active drug compound
Normally, tau proteins exist in a microtubule-bound form, but in AD, tau proteins become hyperphosphorylated, forming NFTs ( In recent years, studies on the use of GLP-1R and GLP-1R agonists to reduce tau protein hyperphosphorylation have progressed
The peptide market has a lot of unreliable suppliers
GLP-1R agonists by reducing de novo lipogenesis and promoting fat oxidation leads to liver fat reduction and liver function improvement in NAFLD patients
More and more evidence is showing that the use of DPP4 Inhibitors and GLP1 Receptor Agonists in combination, is a practice worth changing